340B purchases hit $66.3B in 2023

A total of $66.3 billion in outpatient drugs was purchased through the 340B drug pricing program in 2023, according to data from the Health Resources and Services Administration released Oct. 21. 

Advertisement

The program allows safety-net providers to obtain discounted medications. Disproportionate share hospitals accounted for the largest share of purchases, totaling $51.9 million. Other key purchasers were health center programs ($3.6 billion), children’s hospitals ($2.1 billion), sexually transmitted disease clinics ($1.7 billion), and clinics funded by the Ryan White HIV/AIDS program ($1.5 billion).

High-cost pharmaceuticals purchased through specialty channels made up 60.6% of total 340B purchases, although they accounted for only 36% of units purchased, according to the data. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.